A major breakthrough in the development of stem cell-derived brain cells has put researchers on a firm path towards the first ever stem cell transplantations in people with Parkinson’s disease. A new study presents the next generation of transplantable dopamine neurons produced from stem cells. These cells carry the same properties as the dopamine neurons found in the human brain.
Stem cell transplants for Parkinson’s disease edging closer
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Explore ground-breaking advancements in the treatment of movement disorders in this insightful interview with Prof. K. Ray Chaudhuri, who shares his key takeaways from the 10th Congress of the European Academy of Neurology meeting in Helsinki. He discusses promising new therapies, personalized care approaches, and significant research on the staging of Parkinson's. Additionally, Prof. Chaudhuri emphasizes the importance of holistic treatment, stepped-care strategies, remote management, and the potential of wearable technology in improving patient outcomes, bringing his wealth of knowledge and insights to touchNEUROLOGY
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson's disease. He ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
NEW
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson's Europe. They are the only European Parkinson's umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
NEW
Data emerging from upcoming clinical trials assessing the treatment efficacy in people with clinically established Parkinson’s disease will shed light on optimal treatment approaches. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Slowing down the progression of Parkinson’s disease is key to improving outcomes. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of Padova, Italy) presents the core concept of the Movement Disorders Society Task ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
In an interview with touchNEUROLOGY, Prof. Heinz Reichmann (University of Dresden Medical School, Germany) gave us his insight into his highlights in Parkinson’s disease, the interventions currently under investigation and how he sees management strategies for Parkinson’s disease ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Opicapone has proved effective for the treatment of end-of-dose motor fluctuations in patients with Parkinson’s disease. Here, Prof. Ray Chaudhuri (King's College Hospital, London, UK) discusses the effect of disabling fluctuations and dyskinesias on patient quality of life, efficacy ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Early detection of Parkinson’s disease can vastly improve outcomes. Prof. Tiago Outiero (University Medical Center Goettingen, Goettingen, Germany) discussed with touchNEUROLOGY his research combining basic science to use biological markers and clinical signs to diagnose Parkinson’s disease. Questions: ...
Mark CompleteCompleted
BookmarkBookmarked
NEW
The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals, who are interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
NEW
Prof. Angelo Antonini (Professor of Neurology, University of Padua, Padua, Italy) discusses the key clinical highlights and hot topics in movement disorders and Parkinson's disease. Questions: What are the key clinical highlights from the past year in the field of ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
